Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0236734
Disease: Caffeine related disorders
Caffeine related disorders
0.080 GeneticVariation group BEFREE The athletes received anhydrous caffeine (CAF: 6 mg / kg body mass) or placebo (PLA) 60 minutes before a CrossFit workout with tasks that involved muscle strength, power, gymnastic movements, and metabolic conditioning. 31665873 2020
CUI: C0236734
Disease: Caffeine related disorders
Caffeine related disorders
0.080 Biomarker group BEFREE The adsorption and release of two drugs 5FU (5-fluorouracil) and CAF (caffeine) into and from the ZIF-8 framework were simulated by the Gibbs-ensemble Monte Carlo approach employing two models for representing the sorbent: one without surface (ZIF-8P) and another with surface (ZIF-8S). 31790249 2020
CUI: C0236734
Disease: Caffeine related disorders
Caffeine related disorders
0.080 GeneticVariation group BEFREE Thereafter, during a 15 min simulated half-time period, players chewed either caffeine (CAF: 400 mg; 4.1 ± 0.5 mg·kg) or PL gum for five min before completing a second repeated sprint test (RSSA2). 29210957 2020
CUI: C0236734
Disease: Caffeine related disorders
Caffeine related disorders
0.080 Biomarker group BEFREE Caffeine was administrated during all prenatal and postnatal life (CAF, 0.1 g/l to drink). 30579994 2019
CUI: C0236734
Disease: Caffeine related disorders
Caffeine related disorders
0.080 Biomarker group BEFREE Therefore, we sought to evaluate the effect of frequent caffeine-maltodextrin (CAF-MALT) mouth rinsing on mental fatigue induced by a prolonged cognitive task. 29247343 2018
CUI: C0236734
Disease: Caffeine related disorders
Caffeine related disorders
0.080 Biomarker group BEFREE In this study, the formation of caffeine/dapsone (CAF/DAP) cocrystals by scalable production methods, such as liquid-assisted grinding (LAG) and spray drying, was investigated in the context of the potential use of processed cocrystal powder for pulmonary delivery. 29968042 2018
CUI: C0236734
Disease: Caffeine related disorders
Caffeine related disorders
0.080 Biomarker group BEFREE No correlation was observed between habitual caffeine intake and absolute changes (CAF - CON) in TT performance with caffeine (<i>P</i> = 0.524). 28495846 2017
CUI: C0236734
Disease: Caffeine related disorders
Caffeine related disorders
0.080 GeneticVariation group BEFREE Twenty-four participants completed 4 counterbalanced experimental sessions, during which they performed MR with either placebo (PL), carbohydrate (CHO: 1.6 g/25 mL), guarana complex (GUAc: 0.4 g/25 mL) or caffeine (CAF: 67 mg/25 mL) before and twice during exercise. 28598402 2017